Elanco Animal Health (ELAN) Capital Expenditures Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | -21.54% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 881.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.54% |
| Dec 31, 2025 | 31.91% |
| Sep 30, 2025 | 119.05% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 170.83% |
| Dec 31, 2024 | 14.63% |
| Sep 30, 2024 | 27.27% |
| Jun 30, 2024 | -19.05% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -46.75% |
| Sep 30, 2023 | -8.33% |
| Jun 30, 2023 | -17.65% |
| Mar 31, 2023 | 242.86% |
| Dec 31, 2022 | -47.97% |
| Sep 30, 2022 | 3,700.00% |
| Jun 30, 2022 | 950.00% |
| Mar 31, 2022 | -61.11% |
| Dec 31, 2021 | 428.57% |
| Sep 30, 2021 | -101.14% |
| Jun 30, 2021 | -112.77% |